Welcome to the OMA Blog

Comprehensive obesity management ideally should utilize a spectrum of treatments -- nutrition therapy, physical activity, behavior modifications and medical interventions such as medication management. Medical nutrition therapy is an essential pillar regarding treatment of patients with obesity. Nutrition quality is just as critical as calorie reduction in obesity treatment. By reducing hunger signals, patients may find it easier to adhere to their nutritional goals. The Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH), and plant-forward diets each offer distinct benefits and varying levels of evidence supporting their role in obesity care. Source https://pubmed.ncbi.nlm.nih.gov/32059053/ The Mediterranean diet has the most consistent evidence for weight management and cardiometabolic benefits. The effect of the DASH diet with supervised physical activity decreases body weight, waist circumference, and fat mass. (Source: https://pubmed.ncbi.nlm.nih.go... ) When guiding patients on dietary choices, it is essential to consider cost and accessibility. For clinicians seeking additional guidance, the 2024 OMA Obesity Algorithm—Important Principles for the Effective Treatment of Patients with Obesity is a valuable resource and is free for OMA members.

Obesity is a major risk factor for cardiovascular disease (CVD), contributing to hypertension, dyslipidemia, and metabolic dysfunction. Effective Treatment Strategies for Reducing Cardiovascular Risk A comprehensive approach to obesity treatment can significantly lower cardiovascular risk. Pharmacotherapy plays a critical role in obesity management, particularly for patients at high cardiovascular risk. SGLT2 inhibitors, originally developed for diabetes management, have also shown promise in obesity treatment and cardiovascular protection. These medications offer an innovative approach to obesity and cardiovascular disease management, providing an alternative to or adjunct to traditional lipid-lowering and antihypertensive therapies. The Obesity Medicine Association (OMA) provides a comprehensive Obesity Algorithm® , which outlines individualized treatment strategies, including pharmacologic options tailored to patients with cardiovascular comorbidities. These guidelines reinforce the necessity of an individualized, multidisciplinary approach to obesity management in patients with existing heart disease. Obesity and cardiovascular disease are intricately linked, making obesity management a crucial component of cardiovascular risk reduction. OMA Resources for Clinicians For clinicians seeking to enhance their expertise in obesity and cardiovascular disease management, the Obesity Medicine Association (OMA) offers a variety of resources.

Discover effective lipedema treatment options health providers can use to better support patients and improve long-term outcomes.

Learn about the common symptoms associated with leptin resistance and the best ways to treat patients affected by this issue in our comprehensive guide.

Obesity is a complex, chronic disease that is a major risk factor for other cardiovascular, renal and metabolic conditions, including liver disease and cardiovascular disease. Sandy Sommer, Head of the Therapeutic Area for Cardiovascular, Renal and Metabolic at Boehringer Ingelheim, explains why it is vital that we view obesity and related metabolic conditions through the lens of connectivity.

Deepen your understanding of lipodystrophy—from symptoms and diagnosis to treatment strategies—with our comprehensive guide.

Hypertension in patients with obesity is on the rise. Learn the key risk factors and how to manage them effectively.

Explore the milestones, innovations, and advocacy efforts that have shaped the field, from early beginnings to modern breakthroughs. Join us in honoring the past and advancing the future of obesity medicine.

Explore the relationship between obesity and exercise, including current guidelines, challenges, and benefits beyond weight loss.